Abstract
Aims: Enzyme replacement therapy (ERT) has been shown to improve the outcome in infantile Pompe disease, but information about mortality and morbidity of patients treated outside clinical trials is still limited.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
